🇺🇸 FDA
Patent

US 7759359

Method of treating bladder dysfunction with once-a-day trospium salt formulation

granted A61KA61K31/46A61K9/16

Quick answer

US patent 7759359 (Method of treating bladder dysfunction with once-a-day trospium salt formulation) held by Supernus Pharmaceuticals, Inc. expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/46, A61K9/16, A61K9/1652, A61K9/20